TOKYO —

The pervasive impact of excessive salt consumption extends far beyond its well-established link to hypertension, with emerging scientific evidence indicating significant interference with cognitive function, memory, and emotional well-being. While high salt intake has long been recognized as a critical public health challenge due to its association with elevated blood pressure, the newly illuminated potential for it to impair brain function underscores the urgent need for effective strategies to counteract its harmful consequences. A groundbreaking study conducted by researchers in Japan has identified a promising avenue for such mitigation in LPC70, a compound derived from soy, which exhibits a remarkable capacity to influence crucial chemical signaling pathways in both the kidneys and the brain, thereby potentially safeguarding against the neurological and cardiovascular damage wrought by a high-salt diet.

Unraveling the Mechanism: How a Soy-Derived Compound Intervenes

At the heart of this research lies the intricate role of prostaglandins (PGs), a class of signaling molecules synthesized from the fatty acid arachidonic acid (AA). These potent biomolecules function akin to localized hormones, orchestrating a wide array of physiological processes throughout the body. In the cardiovascular system, prostaglandins are instrumental in regulating blood pressure by governing the dilation and constriction of blood vessels. Their influence within the brain, however, is considerably more complex and context-dependent. Depending on the specific receptors they engage, prostaglandins can elicit signals that either confer neuroprotection or contribute to detrimental processes, potentially impacting memory, cognitive abilities, and emotional responses.

LPC70, a specific form of soy lysolecithin characterized by a high concentration of lysophosphatidylcholine (LPC)—exceeding 70% of its phospholipid content—has previously shown promise in preclinical studies. Earlier investigations had indicated its efficacy in reducing both high blood pressure and cognitive impairments observed in mice subjected to a high-salt diet (HSD). The recent study, published online on May 14, 2026, and appearing in Volume 197 of Neurochemistry International on July 1, 2026, delves deeper into the precise molecular mechanisms underlying these observed benefits. The research team, spearheaded by Professor Akihiro Mouri and Dr. Hisayoshi Kubota, with contributions from Dr. Kazuhiro Kagotani, meticulously examined how LPC70 modulates prostaglandin signaling pathways in mice exposed to an HSD.

Dr. Kubota, the study’s first author, played a pivotal role in the experimental design and execution. His comprehensive analysis encompassed the monitoring of blood pressure, detailed observation of behavioral changes, and in-depth molecular profiling of prostaglandin-associated activity. His meticulous work was instrumental in elucidating the distinct ways in which LPC70 exerts its protective effects across different organ systems implicated in salt-related cardiovascular and cognitive dysfunctions.

Professor Mouri and Dr. Kubota are affiliated with the Department of Regulatory Science for Evaluation and Development of Pharmaceuticals & Devices at Fujita Health University Graduate School of Medical Science, as well as the International Center for Brain Science (ICBS) at Fujita Health University in Japan. Dr. Kagotani’s affiliations include Tsuji Oil Mills Co., Ltd., a key collaborator in this research, and the Tsuji Health and Beauty Science Laboratory at Mie University, Japan.

"Our primary objective was to comprehensively understand the role of LPC70 in orchestrating the intricate changes within PG signaling across various organ systems," stated Professor Mouri. "This collaborative research endeavor originated from a strong partnership with Tsuji Oil Mills Co., Ltd., a company dedicated to the development of naturally derived food ingredients." This collaborative spirit, bridging academic research with industrial innovation, has been crucial in advancing the understanding of naturally occurring compounds for health benefits.

Preclinical Findings: Alleviating Salt-Induced Impairments in Rodent Models

The study commenced with the expected observation that mice consuming a high-salt diet exhibited a significant elevation in blood pressure. However, the detrimental ramifications of excessive sodium intake were not confined to their cardiovascular health alone. Behavioral assessments revealed a marked decrease in social interactivity among these mice, alongside a notable impairment in their ability to recognize previously encountered objects—clear indicators of compromised memory function. Intriguingly, the HSD did not appear to induce substantial alterations in their general motor activity or anxiety-like behaviors. This nuanced pattern suggests that excessive salt intake selectively disrupts more complex cognitive and social functions rather than causing widespread neurological deficits.

The subsequent phase of the research involved supplementing the diets of these mice with LPC70. The results were encouraging: several of the HSD-induced impairments were significantly ameliorated. The animals demonstrated improved blood pressure readings, and their performance on tests designed to assess social interaction and object recognition memory showed marked improvement. These positive outcomes spurred the researchers to investigate the underlying molecular changes occurring within the animals’ kidneys and brains.

Organ-Specific Mechanisms of Protection: Kidneys and Brain Respond Differently

Within the kidneys, the high-salt diet was found to upregulate the expression of two key components involved in prostaglandin signaling: cyclooxygenase-2 (COX-2) and the PGE2 receptor EP3. Both of these factors are implicated in the development of hypertension associated with excessive salt consumption. The administration of LPC70 effectively counteracted these salt-induced increases, suggesting that the compound plays a crucial role in rectifying aberrant kidney signaling pathways that disrupt normal blood pressure regulation. This intervention in the kidneys highlights LPC70’s direct impact on the physiological mechanisms controlling fluid and electrolyte balance, which are heavily influenced by salt intake.

In contrast, the prefrontal cortex, a brain region critically involved in executive functions such as thinking, memory, and social behavior, exhibited a different pattern of response. High salt consumption led to a reduction in the expression of the PGD2 receptor DP1. This receptor is known to mediate protective and anti-inflammatory signaling within the brain. Crucially, LPC70 not only restored the expression of the DP1 receptor but did so without affecting DP2, another PGD2 receptor that has been associated with potentially detrimental effects on neuronal cells. This selective modulation is a significant finding, implying that LPC70 does not broadly inhibit or enhance all prostaglandin activity. Instead, it appears to preferentially bolster signaling pathways that contribute to neuroprotection, thereby offering a plausible explanation for the observed improvements in memory and social behavior in the treated mice. This targeted action suggests a sophisticated mechanism of intervention, preserving beneficial signaling while mitigating harmful effects.

A Surprising Twist: Arachidonic Acid Metabolism and Prostaglandin Synthesis

Adding another layer of complexity to the findings, the research team observed an unexpected alteration in the metabolism of arachidonic acid, the essential precursor for prostaglandin synthesis. Mice on a high-salt diet exhibited lower levels of circulating arachidonic acid. However, upon receiving LPC70, the levels of prostaglandins derived from this fatty acid, specifically PGE2 and PGD2, actually increased. This seemingly paradoxical outcome suggests that under conditions of high salt intake, LPC70 may enhance the body’s efficiency in utilizing the available arachidonic acid to produce crucial prostaglandins. This suggests that LPC70 might act as an amplifier or facilitator of existing prostaglandin synthesis pathways, particularly when challenged by a high-salt environment, rather than simply providing more precursors.

Collectively, these findings paint a picture of a coordinated yet highly selective physiological response. In the kidneys, LPC70 appears to dampen signaling pathways that contribute to hypertension. Conversely, in the brain, it appears to reinstate signaling cascades associated with protection against inflammation and neuronal damage. The compound’s efficacy, therefore, is intricately linked to both the specific organ system involved and the precise prostaglandin receptors being modulated. This nuanced action differentiates LPC70 from more generalized interventions and points towards a highly targeted therapeutic potential.

Implications for Functional Foods and Future Research

The implications of these preclinical findings are substantial, suggesting that LPC70 could evolve into a valuable functional food ingredient for mitigating some of the adverse health consequences associated with excessive salt intake. Its demonstrated ability to improve blood pressure and cognitive performance in animal models raises the tantalizing prospect of its utility in supporting both cardiovascular and brain health, particularly for populations with high dietary salt consumption.

However, it is imperative to acknowledge that these conclusions are derived from animal studies. Extensive clinical trials in humans are indispensable to ascertain whether these beneficial effects translate to human physiology. The transition from rodent models to human subjects is a critical step in the drug and supplement development process, often revealing differences in efficacy and safety profiles.

"Our study provides a clearer understanding of LPC70’s intricate role in prostaglandin signaling, laying a robust foundation for future clinical research and the development of dietary interventions," Professor Mouri concluded. "The ultimate aim is to combat hypertension-related cognitive decline and promote healthy aging on a global scale." This research opens new horizons for nutritional science, exploring how naturally derived compounds can be harnessed to bolster long-term health and well-being in the face of common dietary challenges.

A Glimpse into Research Funding and Collaborative Efforts

This significant research was made possible through substantial financial and logistical support from various esteemed organizations. Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS) provided crucial funding under grant numbers 20K07931, 22K07606, 22K11891, and 23H02843. Further support was channeled through the Fujita Mind-Brain Research & Innovation Center for Drug Generation (Fujita Mind-BRIDGe) as part of Japan’s Peak Research Universities (J-PEAKS) Program (JPJS00420240019), alongside the Japan Science and Technology Agency FOREST Program (JPMJFR215H).

The industrial partner, Tsuji Oil Mills Co., Ltd., provided essential funding for the research, underscoring the synergistic relationship between academia and industry in driving scientific innovation. Additional grants and support were generously supplied by the Education and Research Facility of Animal Models for Human Diseases at Fujita Health University, the Smoking Research Foundation, and the Takeda Science Foundation. This multi-faceted support network highlights the collaborative and resource-intensive nature of cutting-edge scientific discovery. The timeline of this research, from initial concept to publication, reflects a dedicated effort over several years, culminating in findings that could shape future dietary recommendations and interventions. The initial identification of LPC70’s potential likely occurred years prior, with subsequent studies progressively unraveling its complex mechanisms. The publication date of May 14, 2026 (online) and July 1, 2026 (print) indicates a recent culmination of extensive laboratory work and rigorous peer review, positioning these findings at the forefront of current scientific understanding.